Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-09-094512
Filing Date
2009-04-30
Accepted
2009-04-30 16:38:39
Documents
5
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d10ka.htm 10-K/A 295701
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 3228
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 3235
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 4054
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3974
  Complete submission text file 0001193125-09-094512.txt   311695
Mailing Address 10990 WILSHIRE BLVD. SUITE 1200 LOS ANGELES CA 90024
Business Address 10990 WILSHIRE BLVD. SUITE 1200 LOS ANGELES CA 90024 310 943 8040
Cougar Biotechnology, Inc. (Filer) CIK: 0001335102 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33871 | Film No.: 09784386
SIC: 2834 Pharmaceutical Preparations